Effect of EPO administration on myocardial infarct size in patients with non-STE acute coronary syndromes; results from a pilot study.
A pilot study was performed to determine the effect of 40,000 IU Epo on myocardial damage in 51 patients with non-ST segment elevation acute coronary syndrome (non-STE ACS). No significant difference in myocardial damage was found, but an increased systolic blood pressure was noticed.